Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BARRETT M JAMES
Last Updated 
25-Aug-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BARRETT M JAMES: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
26-Dec-14
18-Jul-16
0
   8,752,543
8,752,543
  Direct
  Indirect  
  Total
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
Clovis Oncology, Inc.
Director
NasdaqGS:CLVS
(historical quotes, profile, other insiders)
14-May-15
15-May-15
574
   1,140,464
1,141,038
  Direct
  Indirect  
  Total
CVENT, INC. Common Stock
Beneficial Owner (10% or more)
NYSE:CVT
(historical quotes, profile, other insiders)
25-Nov-14
25-Nov-14
252
   3,996,997
3,997,249
  Direct
  Indirect  
  Total
Tableau Software, Inc. Class A
Beneficial Owner (10% or more)
NYSE:DATA
(historical quotes, profile, other insiders)
2-Dec-14
2-Dec-14
20,522
   83,126
103,648
  Direct
  Indirect  
  Total
Dermira, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DERM
(historical quotes, profile, other insiders)
8-Oct-143,502,922  Indirect
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
12-Jan-166,260,851  Indirect
GlycoMimetics, Inc.
Director
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
16-Nov-158,584,128  Indirect
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
29-Jul-1655,418,811  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
Proteostasis Therapeutics, Inc.
Director
NasdaqGM:PTI
(historical quotes, profile, other insiders)
17-Feb-163,093,072  Indirect
Senseonics Holdings, Inc. Commo
Director
NYSE MKT:SENS
(historical quotes, profile, other insiders)
17-Mar-16
23-Mar-16
494,689
   14,971,064
15,465,753
  Direct
  Indirect  
  Total
Sunesis Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqCM:SNSS
(historical quotes, profile, other insiders)
29-Aug-144,659,333  Indirect
Supernus Pharmaceuticals, Inc.
Director
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
16-Mar-16
8-Dec-15
97,355
   115,355
212,710
  Direct
  Indirect  
  Total
TRACON Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:TCON
(historical quotes, profile, other insiders)
4-Feb-151,888,474  Indirect
TESARO, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
1-Jun-15
18-Mar-16
252
   9,564,936
9,565,188
  Direct
  Indirect  
  Total
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:VTAE
(historical quotes, profile, other insiders)
1-Jul-15
1-Jul-15
464
   1,787,698
1,788,162
  Direct
  Indirect  
  Total
Zosano Pharma Corporation
Beneficial Owner (10% or more)
NasdaqCM:ZSAN
(historical quotes, profile, other insiders)
26-Jan-15
21-Jul-16
5
   2,121,476
2,121,481
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
29-Jul-16 *20,120,724ILIU Purchase at $0.10 per share.
(Cost of $2,012,072)
21-Jul-16 *8,989ZSAN Sale at $1.33 per share.
(Proceeds of $11,955)
20-Jul-16 *14,158ZSAN Sale at $1.24 per share.
(Proceeds of $17,555)
19-Jul-16 *534ZSAN Sale at $1.17 per share.
(Proceeds of $624)
18-Jul-16 *763,650ARDX Purchase at $8.73 per share.
(Cost of $6,666,664)
13-Jul-16 *13,382ZSAN Sale at $1.20 per share.
(Proceeds of $16,058)
23-Mar-16 *1,578,947SENS Purchase at $2.85 - $2.85 per share.
(Cost of about $4,500,000)
18-Mar-16 *710,429TSRO Purchase at $35.19 - $35.19 per share.
(Cost of about $25,000,000)
17-Mar-16 494,689SENS Statement of Ownership
17-Mar-16 *13,392,117SENS Statement of Ownership
16-Mar-16 18,000SUPN Disposition (Non Open Market) at $0 per share.
17-Feb-16 *900,324PTI Purchase at $8 - $8 per share.
(Cost of about $7,203,000)
17-Feb-16 *2,192,748PTI Acquisition (Non Open Market)
13-Jan-16 *500,000ARDX Purchase at $10 per share.
(Cost of $5,000,000)
12-Jan-16 *1,111,111EPZM Purchase at $9 - $9 per share.
(Cost of about $10,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
8-Dec-15 *70,913SUPN Sale at $14.75 - $14.75 per share.
(Proceeds of about $1,046,000)
7-Dec-15 *71,067SUPN Sale at $14.38 - $14.38 per share.
(Proceeds of about $1,022,000)
4-Dec-15 *70,990SUPN Sale at $14.54 - $14.54 per share.
(Proceeds of about $1,032,000)
3-Dec-15 *1,427,328SUPN Acquisition (Non Open Market) at $0 per share.
3-Dec-15 41,426SUPN Acquisition (Non Open Market) at $0 per share.
3-Dec-15 *4,993,557SUPN Disposition (Non Open Market) at $0 per share.
25-Nov-15 16,179SUPN Sale at $16.35 - $16.35 per share.
(Proceeds of about $265,000)
25-Nov-15 16,179SUPN Option Exercise at $7.90 - $9.24 per share.
(Cost of about $139,000)
18-Nov-15 *43,000SUPN Sale at $16.50 - $16.5 per share.
(Proceeds of about $710,000)
17-Nov-15 *50,000SUPN Sale at $16.71 - $16.71 per share.
(Proceeds of about $836,000)
16-Nov-15 *452GLYC Sale at $6.91 - $6.91 per share.
(Proceeds of about $3,123)
16-Nov-15 *9,445GLYC Option Exercise at $0.33 - $0.33 per share.
(Cost of about $3,116)
16-Nov-15 *19,650SUPN Sale at $16.13 - $16.13 per share.
(Proceeds of about $317,000)
13-Nov-15 *100,000SUPN Sale at $16.26 - $16.26 per share.
(Proceeds of about $1,626,000)
11-Nov-15 *1,426,987SUPN Acquisition (Non Open Market) at $0 per share.
11-Nov-15 *4,993,557SUPN Disposition (Non Open Market) at $0 per share.
11-Nov-15 41,405SUPN Acquisition (Non Open Market) at $0 per share.
6-Oct-15 *857,142MIRN Purchase at $7 - $7 per share.
(Cost of about $6,000,000)
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
1-Jul-15 *9,384VTAE Acquisition (Non Open Market) at $0 per share.
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
1-Jul-15 464VTAE Acquisition (Non Open Market) at $0 per share.
17-Jun-15 *111,881SUPN Sale at $16.02 - $16.67 per share.
(Proceeds of about $1,829,000)
16-Jun-15 *55,105SUPN Sale at $16.85 - $16.85 per share.
(Proceeds of about $929,000)
15-Jun-15 *1,120,510SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 32,524SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
5-Jun-15 *1,869,159ARDX Purchase at $10.70 - $10.7 per share.
(Cost of about $20,000,000)
2-Jun-15 *2,129TSRO Sale at $57.55 - $58.13 per share.
(Proceeds of about $123,000)
1-Jun-15 *12,381TSRO Acquisition (Non Open Market) at $0 per share.
1-Jun-15 252TSRO Acquisition (Non Open Market) at $0 per share.
1-Jun-15 *1,010,000TSRO Disposition (Non Open Market) at $0 per share.
15-May-15 *2,424CLVS Sale at $91.86 - $92.57 per share.
(Proceeds of about $224,000)
14-May-15 287CLVS Acquisition (Non Open Market) at $0 per share.
14-May-15 *1,151,290CLVS Disposition (Non Open Market) at $0 per share.
14-May-15 *14,110CLVS Acquisition (Non Open Market) at $0 per share.
4-Feb-15 *1,388,474TCON Acquisition (Non Open Market)
4-Feb-15 *500,000TCON Purchase at $10 - $10 per share.
(Cost of about $5,000,000)
30-Jan-15 *23,457ZSAN Purchase at $11 per share.
(Cost of $258,027)
30-Jan-15 *341,201ZSAN Acquisition (Non Open Market) at $9.35 - $9.35 per share.
(Value of about $3,190,000)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
26-Jan-15 5ZSAN Statement of Ownership
26-Jan-15 *1,793,881ZSAN Statement of Ownership
22-Jan-15 *162,780BOX Statement of Ownership
26-Dec-14 *2,268ARDX Sale at $21.28 - $21.54 per share.
(Proceeds of about $49,000)
26-Dec-14 296ARDX Sale at $21.54 - $21.54 per share.
(Proceeds of about $6,375)
23-Dec-14 296ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
23-Dec-14 *2,268ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 *19,868,965ILIU Purchase at $0.10 per share.
(Cost of $1,986,896)
2-Dec-14 *1,716,876DATA Acquisition (Non Open Market) at $0 per share.
2-Dec-14 13,553DATA Acquisition (Non Open Market) at $0 per share.
2-Dec-14 *1,633,750DATA Disposition (Non Open Market) at $0 per share.
25-Nov-14 252CVT Acquisition (Non Open Market) at $0 per share.
25-Nov-14 *12,891CVT Acquisition (Non Open Market) at $0 per share.
25-Nov-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
8-Oct-14 *69,112DERM Purchase at $16 - $16 per share.
(Cost of about $1,106,000)
8-Oct-14 *3,416,569DERM Acquisition (Non Open Market) at $0 per share.
2-Oct-14 *17,241DERM Statement of Ownership
29-Aug-14 *11,600SNSS Sale at $7.51 - $7.51 per share.
(Proceeds of about $87,000)
28-Aug-14 *146,800SNSS Sale at $7.87 - $7.87 per share.
(Proceeds of about $1,155,000)
27-Aug-14 *108,300SNSS Sale at $8.17 - $8.17 per share.
(Proceeds of about $885,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?